Correction to: Immunogenicity and safety of the mRNA-based BNT162b2 vaccine in systemic autoimmune rheumatic diseases patients.
Clin Rheumatol
; 41(12): 3925, 2022 Dec.
Article
in En
| MEDLINE
| ID: mdl-36251175
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Clin Rheumatol
Year:
2022
Document type:
Article
Affiliation country:
Israel